Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 29, 2020

SELL
$71.87 - $131.03 $1.01 Million - $1.83 Million
-14,000 Closed
0 $0
Q2 2020

Jul 22, 2020

BUY
$79.55 - $124.22 $1.11 Million - $1.74 Million
14,000 New
14,000 $1.73 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Railway Pension Investments LTD Portfolio

Follow Railway Pension Investments LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Railway Pension Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Railway Pension Investments LTD with notifications on news.